These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1905068

  • 21. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
    Sills ES, Drews CD, Perloe M, Tucker MJ, Kaplan CR, Palermo GD.
    Gynecol Endocrinol; 2003 Jun; 17(3):231-7. PubMed ID: 12857431
    [Abstract] [Full Text] [Related]

  • 22. [Changes in tissue plasminogen activator and plasminogen activator inhibitor during administration of nitroglycerine into internal thoracic artery in dogs with acute myocardial ischemia].
    Wu X, Wang CF, Sheng J, Zhu J.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):527-9. PubMed ID: 15355613
    [Abstract] [Full Text] [Related]

  • 23. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T, Sakakibara K, Rydzewski A, Urano S, Takada Y, Takada A.
    Thromb Haemost; 1990 Feb 19; 63(1):82-6. PubMed ID: 2111051
    [Abstract] [Full Text] [Related]

  • 24. Plasminogen activator inhibitor 1 and insulin levels in various insulin resistance states.
    Scelles V, Raccah D, Alessi MC, Vialle JM, Juhan-Vague I, Vague P.
    Diabete Metab; 1992 Feb 19; 18(1):38-42. PubMed ID: 1563535
    [Abstract] [Full Text] [Related]

  • 25. Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-1 levels.
    Juhan-Vague I, Alessi MC, Raccah D, Aillaud MF, Billerey M, Ansaldi J, Philip-Joet C, Vague P.
    Thromb Haemost; 1992 Jan 23; 67(1):76-82. PubMed ID: 1615488
    [Abstract] [Full Text] [Related]

  • 26. [Tissue plasminogen activator (T-PA) and tissue plasminogen activator inhibitor (PAI-1) in patients after head injury].
    Beuth W, Kotschy M, Kasprzak HA, Rość D, Osiński P, Sniegocki M.
    Neurol Neurochir Pol; 1996 Jan 23; 30(3):427-34. PubMed ID: 8965977
    [Abstract] [Full Text] [Related]

  • 27. [t-PA and PAI in patients with Raynaud's syndrome in treatment with a stable prostacyclin analog].
    Pola P, de Martini D, Gerardino L.
    Angiologia; 1992 Jan 23; 44(2):62-6. PubMed ID: 1378247
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke].
    Han XM, Chen ZQ, Mao HM.
    Zhonghua Nei Ke Za Zhi; 1990 Sep 23; 29(9):544-6, 575-6. PubMed ID: 2128260
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM)].
    Jokaji H, Asakura H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T.
    Nihon Ronen Igakkai Zasshi; 1990 Nov 23; 27(6):699-705. PubMed ID: 2127812
    [Abstract] [Full Text] [Related]

  • 32. [The changes in molecular markers for hemostatic activation after t-PA therapy in case of pulmonary embolism].
    Masuoka H, Hiraoka N, Inden M, Fujioka H, Konishi T, Nakano T, Deguchi K.
    Kokyu To Junkan; 1992 Apr 23; 40(4):407-10. PubMed ID: 1315073
    [Abstract] [Full Text] [Related]

  • 33. [Plasma tissue-type plasminogen activator and plasminogen activator inhibitor activities and their ratio in patients with ischemic stroke associated with stagnation of blood during various stages].
    Han XM.
    Zhong Xi Yi Jie He Za Zhi; 1991 Jan 23; 11(1):17-9, 3-4. PubMed ID: 1905203
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1.
    Andreotti F, Kluft C, Davies GJ, Huisman LG, de Bart AC, Maseri A.
    Am J Cardiol; 1991 Nov 15; 68(13):1295-9. PubMed ID: 1951115
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.